25 LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

25 LLC’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-98	Closed	-$1.01K	–	267
2023 Q2	$1.01K	Buy	+98	New	+$1.05K	﹤0.01%	288

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

25 LLC's IRWD Position: Q3 2023 in Review

25 LLC sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2023, closing a stake of 98 shares — an estimated $1.01K sold.

25 LLC first reported a position in IRWD in Q2 2023 and held it in 1 quarter. The position peaked at $1.01K in Q2 2023. 248 funds tracked by Wall St. Rank hold IRWD as of Q3 2023.

25 LLC reported no remaining Ironwood Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
25 LLC sold 98 Ironwood Pharmaceuticals shares in Q3 2023, an estimated $1.01K.
25 LLC first reported a position in Ironwood Pharmaceuticals in Q2 2023 and held it in 1 quarter.
25 LLC's Ironwood Pharmaceuticals position peaked at $1.01K in Q2 2023.
248 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.